Floatz logo

il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells

Recurrent Glioblastoma

City of Hope Medical CenterCell therapyPhase 1Active
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

39 Active assets in the Recurrent Glioblastoma cohort.

Asset / SponsorPhaseRating
Cediranib
M.D. Anderson Cancer Center
Phase 3BB
Niraparib
Ivy Brain Tumor Center
Phase 3BB
FLUDEOXYGLUCOSE
Jonsson Comprehensive Cancer Center
Phase 2B
Atezolizumab
Centre Hospitalier Universitaire Vaudois
Phase 2B
Monomethyl Fumarate
Alliance for Clinical Trials in Oncology
Phase 2/3B

View all 50 →

Same molecule, other indications

il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells is also rated in:

cutaneous melanomaDormant
CC
Indicative ·
43 / 100
View asset →
paragangliomaDormant
CC
Indicative ·
43 / 100
View asset →
pheochromocytomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →